NeoGenomics, Inc. (NEO): Price and Financial Metrics

NeoGenomics, Inc. (NEO)

Today's Latest Price: $53.77 USD

0.99 (1.88%)

Updated Jan 19 4:00pm

Add NEO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 64 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

NEO Stock Summary

  • NEO's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 410.11 -- higher than 91.11% of US-listed equities with positive expected earnings growth.
  • With a price/sales ratio of 13.78, Neogenomics Inc has a higher such ratio than 86.82% of stocks in our set.
  • In terms of twelve month growth in earnings before interest and taxes, Neogenomics Inc is reporting a growth rate of -288.73%; that's higher than only 6.93% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Neogenomics Inc are VSAT, PRGO, THR, PEN, and QBAK.
  • NEO's SEC filings can be seen here. And to visit Neogenomics Inc's official web site, go to

NEO Stock Price Chart Interactive Chart >

Price chart for NEO

NEO Price/Volume Stats

Current price $53.77 52-week high $57.07
Prev. close $52.78 52-week low $20.47
Day low $53.11 Volume 1,003,500
Day high $55.25 Avg. volume 1,553,582
50-day MA $49.32 Dividend yield N/A
200-day MA $37.75 Market Cap 5.97B

NeoGenomics, Inc. (NEO) Company Bio

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company was founded in 2001 and is based in Fort Myers, Florida.

NEO Latest News Stream

Event/Time News Detail
Loading, please wait...

NEO Latest Social Stream

Loading social stream, please wait...

View Full NEO Social Stream

Latest NEO News From Around the Web

Below are the latest news stories about Neogenomics Inc that investors may wish to consider to help them evaluate NEO as an investment opportunity.

NeoGenomics prices stock and debt offering

NeoGenomics (NEO) has priced concurrent public offerings of (a) 4,081,632 common shares at $49.00/share for gross proceeds of $200M and (b) $300M aggregate principal amount of its 0.25% convertible senior notes due 2028.Underwriters' over-allotment is an additional 612,244 shares and $45M of the notes. The initial conversion rate is 15.1172...

Seeking Alpha | January 7, 2021

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

FORT MYERS, FL / ACCESSWIRE / January 6, 2021 / NeoGenomics, Inc.

Yahoo | January 7, 2021

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

FORT MYERS, FL / ACCESSWIRE / January 5, 2021 / NeoGenomics, Inc.

Yahoo | January 5, 2021

NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference

MYERS, FL / ACCESSWIRE / January 4, 2021 / NeoGenomics, Inc.

Yahoo | January 4, 2021

NeoGenomics: ~27% Upside Potential Is Under-Reflected, Market Is Unfairly Discounting Shares

Investment Thesis We are long NeoGenomics (NEO) shares and hold a bullish long-term sentiment based on fundamental momentum, key differentiators within the portfolio mix and acquisition success over the previous periods for the company. NEO sits at the tip of the spear for our high-quality-growth-at-a-reasonable-price ("HQ-GARP") list and offers a...

Zach Bristow on Seeking Alpha | December 22, 2020

Read More 'NEO' Stories Here

NEO Price Returns

1-mo 0.28%
3-mo 27.63%
6-mo 46.43%
1-year N/A
3-year 572.97%
5-year 680.41%
YTD -0.13%
2020 84.07%
2019 131.96%
2018 42.33%
2017 3.38%
2016 8.89%

Continue Researching NEO

Here are a few links from around the web to help you further your research on Neogenomics Inc's stock as an investment opportunity:

Neogenomics Inc (NEO) Stock Price | Nasdaq
Neogenomics Inc (NEO) Stock Quote, History and News - Yahoo Finance
Neogenomics Inc (NEO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7927 seconds.